IL13 and renal fibrosis: And Simvastatin can directly inhibit the STAT6 pathway activated by interleukin-13 (IL-13), thereby inhibiting the activation of myeloid fibroblasts and the development of renal fibrosis (Yan et al., 2015; Maneechotesuwan et al., 2016).